Tradestie Institutional Equity Comparison Engine

CRCA vs CCUP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CCUP Overall Edge

CCUP Captures Institutional Edge (1โ€“1 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to T-REX 2X Long CRCL Daily Target ETF (CCUP) driven by superior Momentum & Technical while CRCA counters with relative strength in Options & Structure. Fundamentally, CRCA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CCUP at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CRCA sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against CCUP sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CRCA N/M vs CCUP N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner CCUP
1Y +54.1% vs +71.8% ยท 52W Pos 4% vs 15%
Options & Structure Winner CRCA
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (50th %ile IV)
CRCA NYSE Arca
ProShares Ultra CRCL
Institutional Equity
$5.24
-16.43% 1D
Market Cap N/A
1M Return -71.93%
1Y Return +54.12%
Forward P/E N/M
Unified AI Score
48.5 / 100 HOLD
Tech 45.0 Fund 49.0 Flow 50.0 Mom 55.0
CCUP Cboe BZX
T-REX 2X Long CRCL Daily Target ETF
Institutional Equity
$6.27
-17.82% 1D
Market Cap N/A
1M Return -71.95%
1Y Return +71.78%
Forward P/E N/M
Unified AI Score
53.6 / 100 HOLD
Tech 45.0 Fund 49.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRCA +54.12% CCUP +71.78% Spread: +17.66 pp (CCUP Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CRCA TTM Op. Margin: N/A CCUP TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRCA vs CCUP. Trailing 12-month operating profitability (CRCA N/A vs CCUP N/A) and valuation multiples (CRCA N/M vs CCUP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRCA (1) vs CCUP (2)
Institutional Metric CRCA CCUP Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 4% ($1โ€“$93) 15% ($1โ€“$35) Stronger Trend CCUP
Beta / 30D Volatility Risk Regime 4.84ฮฒ ยท 120% Vol 3.02ฮฒ ยท 122% Vol Lower Realized Risk CRCA
Unified Institutional Score Composite Signal 48.5 / 100 (HOLD) 53.6 / 100 (HOLD) Higher Composite CCUP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRCA vs CCUP Buy Guide
CRCA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live CRCA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CCUP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CCUP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRCA nor CCUP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.